Skip to main content
Contact Us
Subscribe
E-Edition
86°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's Disease
Recent news which mentions Alzheimer's Disease
< Previous
1
2
3
Next >
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
February 09, 2024
Tags
Health insurance
Alzheimer's disease
Long/Term Care
From
CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
General
IONS
Biotech
From
Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
December 04, 2023
Tickers
CBD
Tags
General
Markets
Cannabis
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
ESAIY
PRTA
BIIB
From
Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
September 30, 2023
Tags
Dementia
Make It / Life
Alzheimer's disease
From
CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
August 24, 2023
Tickers
TECH
Tags
Success Stories
Dr/ Itzhak Kurek
Market News
From
Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
August 03, 2023
Tags
Podcasting
Alzheimer's disease
Health
From
CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
Tickers
POTX
TOKE
Tags
Biotech
Cannabis Puerto Rico
Alzheimer's disease
From
Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
July 20, 2023
Tags
Dementia
Elder care
Retirement planning
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Biotechnology
Biogen Inc
Companies
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Alzheimer's disease
Science
Business
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Health care industry
Eisai Co Ltd
Regulations
From
CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
Tickers
ALZN
BIIB
LLY
SAVA
Tags
alzheimer's treatment
Small Cap
General
From
Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Eisai Co Ltd
Health care industry
Policy
From
CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
June 22, 2023
Tags
Respiratory Synctial Virus (RSV)
Alzheimer's Disease
Mammogram
From
Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
June 21, 2023
Tags
Alzheimer's disease
Benzinga
Alleh Lindquist
From
Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Business
Alzheimer's disease
Breaking News: Business
From
CNBC.com News
Medicare details plan to cover Alzheimer's treatments
June 01, 2023
Tags
Biotech and Pharmaceuticals
Politics
U/S/ Economy
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Biotechnology
Biogen Inc
US: News
From
CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Policy
Coronavirus
U/S/ Economy
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Eli Lilly and Co
Health care industry
Politics
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Biogen Inc
Biotechnology
US: News
From
CNBC.com News
March 2023 Miscellany
March 27, 2023
Tags
Cancer
Eli Lilly (LLY)
Roche (RHHBF RHHBY)
From
Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
Tags
NervGen Pharma (NGEN/V NGENF)
Cassava Sciences (SAVA)
Doc Gumshoe
From
Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
Tags
Bavarian Nordic (BAVA/CO BVNRY BVNKF)
Merck (MRK)
Doc Gumshoe
From
Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Tickers
MOR
RHHBF
RHHBY
RHHVF
Tags
RHHBF
General
Small Cap
From
Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
Tags
Health Tips and Wellness Advice
Longevity rates
Lifestyle
From
CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
November 07, 2022
Tickers
SPRC
Tags
General
medical cannabis
Alzheimer's disease
From
Benzinga
Odd & Ends – October 2022
October 27, 2022
Tags
Eisai (ESALY)
Alzheimer's Disease
ALS / Lou Gehrig's Disease
From
Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Tickers
ABOS
ACIU
ALZN
ANVS
Tags
LGVN
Alzheimer’s
News
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.